Collaboration is central to how we advance precision oncology. By working with partners across therapeutics, diagnostics, medtech, and manufacturing, we accelerate the development of radiopharmaceuticals that help patients live longer, better lives.
Our Business Development and Alliance Management team works closely with collaborators to evaluate opportunities in confidence, build flexible structures, and execute against the goals of strategic partnerships — ranging from licensing and co-development to strategic M&A — that strengthen the global radiopharmaceutical ecosystem.
We partner on high-impact theranostic programs in oncology, spanning urologic and neurologic cancers as well as other solid tumors and hematologic malignancies, focusing on assets with established proof of concept that can benefit from our fully integrated radiopharmaceutical platform and strengthen Telix’s pipeline, platform and long-term growth.
Our precision medicine partnerships advance molecular imaging and complementary therapeutic approaches to improve cancer care. We work with innovators developing PET and SPECT agents and novel therapies that expand our precision medicine and therapeutic portfolio and support a theranostic approach across oncology.
We collaborate on technologies for image-guided treatment of cancers. Partnerships span workflow enhancement, dosimetry and therapy planning, and decision-support systems that make care more precise and efficient.
Through Telix Manufacturing Solutions, we work with partners to strengthen global radiopharmaceutical production. Focus areas include isotope technologies, purification, automation and large-scale formulation for diagnostic and therapeutic isotopes worldwide.
We support early innovation in radiopharmaceutical science — from novel radiochemistry and chelation to new targeting agents and tumor-microenvironment approaches that open future paths in cancer treatment.
As a fully integrated radiopharmaceutical company, Telix brings expertise spanning research, clinical development, regulatory, manufacturing and commercialization. Our partnership model is built on flexibility, collaboration and strategic alignment, supported by a global infrastructure that accelerates development and creates mutual value across partnerships, licensing and other strategic transactions.
Unlock the full potential of your theranostic programs with us.
Ready to discuss partnership opportunities? Please reach out to our Business Development & Alliance Management team.